Intelligence Profile
Clinical Applications
Testosterone enanthate is primarily used as testosterone replacement therapy for various hypogonadal conditions and developmental disorders. The available evidence shows applications across several clinical scenarios:
Hypogonadism and Testosterone Deficiency
Clinical trials demonstrate testosterone enanthate's use in treating male hypogonadism, including a completed Phase 3 study examining its effects on fatigue in hypogonadal men with advanced cancer (NCT00965341). A Phase 2 pharmacokinetic study evaluated oral testosterone ester formulations in hypogonadal men (NCT02697188), though specific efficacy outcomes from these trials are not detailed in the available evidence.
One study found that testosterone replacement therapy combined with exercise showed efficacy on body composition in hypogonadal men, though the specific magnitude of effects is not provided in the available evidence.
Pediatric Applications
Research shows testosterone enanthate has several applications in pediatric endocrinology:
Constitutional Delay of Growth and Puberty: A systematic review and meta-analysis examined testosterone therapy in boys with constitutional delay, though specific findings are not detailed in the available evidence.
Self-Limited Delayed Puberty: One study found that low-dose testosterone treatment improved wellbeing and emotional state in boys with self-limited delayed puberty, suggesting benefits beyond physical development.
Micropenis Treatment: Research demonstrates use in treating micropenis associated with partial androgen insensitivity syndrome, though treatment outcomes are not specified in the available evidence.
Specialized Applications
Hypospadias Repair: Studies have investigated preoperative intramuscular testosterone use before primary hypospadias repair, specifically examining its relationship to urethrocutaneous fistula formation, though the findings are not detailed in the available evidence.
Spinal Cord Injury: A Phase 2 trial is investigating testosterone combined with locomotor training to promote bone and muscle health after spinal cord injury (NCT04460872), indicating potential applications in rehabilitation medicine.
Cancer Treatment: Research has explored testosterone's role in cancer therapy, including a completed Phase 2 study examining whether testosterone revival could abolish negative symptoms and modulate enzalutamide resistance (NCT02286921).
Evidence Limitations
The available evidence provides limited detail on specific clinical outcomes, dosing protocols, or comparative effectiveness data. Several promising applications are supported by ongoing or completed trials, but detailed efficacy and safety results are not provided in the current evidence base.
This information is for educational purposes only and should not replace professional medical advice. Consult with a qualified healthcare provider for personalized treatment recommendations.